Pharmacoproteomics is a rapidly advancing field in which the techniques of proteomics are applied to develop pharmaceutical agents. The word itself was coined only in 1997. However, this branch of study plays a major role in personalized medicine. The word proteomics itself means the study of proteomes, a proteome being the full complement of proteins expressed by an organism or tissue under specified conditions at a specified time. Proteomes are therefore dynamic, and a given human may have a proteome with as many as two million proteins. The use of this full set of proteins to study the effect of disease or drugs can substitute for much more complex assays in pharmacodynamics at a lower cost in time, financial output, and clinical risk. Pharmacoproteomics is the use of proteomic technologies in drug discovery and development. Along with pharmacogenomics and pharmacogenetics, pharmacoproteomics will play an important role in the development of personalized medicines in several ways. Proteomic technologies are contributing to molecular diagnostics, which is a basis of personalized medicine. Pharmacoproteomics is a more functional representation of patient-to-patient variation than that provided by genotyping. Proteomics-based characterization of multifactorial diseases may help to match a particular target-based therapy to a particular marker in a subgroup of patients. Individualized therapy may be based on differential protein expression rather than a genetic polymorphism. Finally, proteomic technologies would enable discovery and development of drugs suitable for personalized therapy. Protein chips will be used increasingly in clinical diagnostics in the next 5 years, particularly in the point-of-care diagnostics. This will facilitate the practice of personalized medicine in the clinic by the end of this decade. The information can be published in our peer reviewed journal with impact factors and are calculated using citations not only from research articles but also review articles (which tend to receive more citations), editorials, letters, meeting abstracts, short communications, and case reports. The inclusion of these publications provides the opportunity for editors and publishers to manipulate the ratio used to calculate the impact factor and try to increase their number rapidly. Impact factor plays a major role for the particular journal. Journal with higher impact factor is considered to be more important than other ones.